Lepromatous leprosy: dapsone resistance.
D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005260:Female; D005531:Foot Deformities, Acquired; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008875:Middle Aged
D003622:Dapsone; D002991:Clofazimine